263 related articles for article (PubMed ID: 10600101)
21. The FAD-shielding residue Phe1395 regulates neuronal nitric-oxide synthase catalysis by controlling NADP+ affinity and a conformational equilibrium within the flavoprotein domain.
Konas DW; Zhu K; Sharma M; Aulak KS; Brudvig GW; Stuehr DJ
J Biol Chem; 2004 Aug; 279(34):35412-25. PubMed ID: 15180983
[TBL] [Abstract][Full Text] [Related]
22. Flavin mononucleotide-binding domain of the flavoprotein component of the sulfite reductase from Escherichia coli.
Coves J; Zeghouf M; Macherel D; Guigliarelli B; Asso M; Fontecave M
Biochemistry; 1997 May; 36(19):5921-8. PubMed ID: 9153434
[TBL] [Abstract][Full Text] [Related]
23. EPR spectroscopic characterization of neuronal NO synthase.
Galli C; MacArthur R; Abu-Soud HM; Clark P; Steuhr DJ; Brudvig GW
Biochemistry; 1996 Feb; 35(8):2804-10. PubMed ID: 8611587
[TBL] [Abstract][Full Text] [Related]
24. Conformation-dependent hydride transfer in neuronal nitric oxide synthase reductase domain.
Welland A; Daff S
FEBS J; 2010 Sep; 277(18):3833-43. PubMed ID: 20718865
[TBL] [Abstract][Full Text] [Related]
25. Intraprotein electron transfer in a two-domain construct of neuronal nitric oxide synthase: the output state in nitric oxide formation.
Feng C; Tollin G; Holliday MA; Thomas C; Salerno JC; Enemark JH; Ghosh DK
Biochemistry; 2006 May; 45(20):6354-62. PubMed ID: 16700546
[TBL] [Abstract][Full Text] [Related]
26. One-electron reduction of quinones by the neuronal nitric-oxide synthase reductase domain.
Matsuda H; Kimura S; Iyanagi T
Biochim Biophys Acta; 2000 Jul; 1459(1):106-16. PubMed ID: 10924903
[TBL] [Abstract][Full Text] [Related]
27. Role of glutamate-59 hydrogen bonded to N(3)H of the flavin mononucleotide cofactor in the modulation of the redox potentials of the Clostridium beijerinckii flavodoxin. Glutamate-59 is not responsible for the pH dependency but contributes to the stabilization of the flavin semiquinone.
Bradley LH; Swenson RP
Biochemistry; 1999 Sep; 38(38):12377-86. PubMed ID: 10493805
[TBL] [Abstract][Full Text] [Related]
28. Importance of the domain-domain interface to the catalytic action of the NO synthase reductase domain.
Welland A; Garnaud PE; Kitamura M; Miles CS; Daff S
Biochemistry; 2008 Sep; 47(37):9771-80. PubMed ID: 18717591
[TBL] [Abstract][Full Text] [Related]
29. Crystal structure of the FAD/NADPH-binding domain of rat neuronal nitric-oxide synthase. Comparisons with NADPH-cytochrome P450 oxidoreductase.
Zhang J; Martàsek P; Paschke R; Shea T; Siler Masters BS; Kim JJ
J Biol Chem; 2001 Oct; 276(40):37506-13. PubMed ID: 11473123
[TBL] [Abstract][Full Text] [Related]
30. Thermodynamics of oxidation-reduction reactions in mammalian nitric-oxide synthase isoforms.
Gao YT; Smith SM; Weinberg JB; Montgomery HJ; Newman E; Guillemette JG; Ghosh DK; Roman LJ; Martasek P; Salerno JC
J Biol Chem; 2004 Apr; 279(18):18759-66. PubMed ID: 14715665
[TBL] [Abstract][Full Text] [Related]
31. Direct measurement by laser flash photolysis of intraprotein electron transfer in a rat neuronal nitric oxide synthase.
Feng C; Tollin G; Hazzard JT; Nahm NJ; Guillemette JG; Salerno JC; Ghosh DK
J Am Chem Soc; 2007 May; 129(17):5621-9. PubMed ID: 17425311
[TBL] [Abstract][Full Text] [Related]
32. A bridging interaction allows calmodulin to activate NO synthase through a bi-modal mechanism.
Tejero J; Haque MM; Durra D; Stuehr DJ
J Biol Chem; 2010 Aug; 285(34):25941-9. PubMed ID: 20529840
[TBL] [Abstract][Full Text] [Related]
33. Versatile regulation of neuronal nitric oxide synthase by specific regions of its C-terminal tail.
Tiso M; Tejero J; Panda K; Aulak KS; Stuehr DJ
Biochemistry; 2007 Dec; 46(50):14418-28. PubMed ID: 18020458
[TBL] [Abstract][Full Text] [Related]
34. Azo reduction of methyl red by neuronal nitric oxide synthase: the important role of FMN in catalysis.
Miyajima M; Sagami I; Daff S; Taiko Migita C; Shimizu T
Biochem Biophys Res Commun; 2000 Sep; 275(3):752-8. PubMed ID: 10973794
[TBL] [Abstract][Full Text] [Related]
35. Stopped-flow kinetic studies of flavin reduction in human cytochrome P450 reductase and its component domains.
Gutierrez A; Lian LY; Wolf CR; Scrutton NS; Roberts GC
Biochemistry; 2001 Feb; 40(7):1964-75. PubMed ID: 11329263
[TBL] [Abstract][Full Text] [Related]
36. Functional interactions in cytochrome P450BM3. Evidence that NADP(H) binding controls redox potentials of the flavin cofactors.
Murataliev MB; Feyereisen R
Biochemistry; 2000 Oct; 39(41):12699-707. PubMed ID: 11027150
[TBL] [Abstract][Full Text] [Related]
37. Stopped-flow kinetic studies of electron transfer in the reductase domain of neuronal nitric oxide synthase: re-evaluation of the kinetic mechanism reveals new enzyme intermediates and variation with cytochrome P450 reductase.
Knight K; Scrutton NS
Biochem J; 2002 Oct; 367(Pt 1):19-30. PubMed ID: 12079493
[TBL] [Abstract][Full Text] [Related]
38. The FMN-binding domain of cytochrome P450BM-3: resolution, reconstitution, and flavin analogue substitution.
Haines DC; Sevrioukova IF; Peterson JA
Biochemistry; 2000 Aug; 39(31):9419-29. PubMed ID: 10924137
[TBL] [Abstract][Full Text] [Related]
39. Human neuronal nitric oxide synthase can catalyze one-electron reduction of adriamycin: role of flavin domain.
Fu J; Yamamoto K; Guan ZW; Kimura S; Iyanagi T
Arch Biochem Biophys; 2004 Jul; 427(2):180-7. PubMed ID: 15196992
[TBL] [Abstract][Full Text] [Related]
40. Role of reductase domain cluster 1 acidic residues in neuronal nitric-oxide synthase. Characterization of the FMN-FREE enzyme.
Adak S; Ghosh S; Abu-Soud HM; Stuehr DJ
J Biol Chem; 1999 Aug; 274(32):22313-20. PubMed ID: 10428800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
